Schonfeld Strategic Advisors LLC - TRILLIUM THERAPEUTICS INC ownership

TRILLIUM THERAPEUTICS INC's ticker is and the CUSIP is 89620X506. A total of 29 filers reported holding TRILLIUM THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Schonfeld Strategic Advisors LLC ownership history of TRILLIUM THERAPEUTICS INC
ValueSharesWeighting
Q2 2021$6,801,000
+23.2%
701,201
+36.4%
0.07%
+7.5%
Q1 2021$5,522,000
-34.3%
514,175
-10.1%
0.07%
-40.7%
Q4 2020$8,410,000
+4.0%
571,675
+0.4%
0.11%
-26.6%
Q3 2020$8,088,000
+25.1%
569,154
-28.8%
0.15%
+77.0%
Q2 2020$6,464,000
+840.9%
799,000
+370.0%
0.09%
+102.3%
Q1 2020$687,000
+449.6%
170,000
+671.1%
0.04%
+168.8%
Q4 2016$125,000
-57.8%
22,047
+10.2%
0.02%
-68.0%
Q3 2016$296,000
+64.4%
20,0000.0%0.05%
+25.0%
Q2 2016$180,000
+80.0%
20,000
+84.5%
0.04%
-2.4%
Q1 2016$100,00010,8410.04%
Other shareholders
TRILLIUM THERAPEUTICS INC shareholders Q1 2016
NameSharesValueWeighting ↓
NEA Management Company, LLC 2,100,000$646,0000.05%
Matrix Capital Management Company, LP 2,288,560$704,0000.02%
Tekla Capital Management LLC 446,099$137,0000.01%
Realta Investment Advisors 26,000$7,0000.00%
Virtu Financial LLC 34,991$11,0000.00%
Baker Brothers Advisors 505,262$155,0000.00%
BOOTHBAY FUND MANAGEMENT, LLC 20,044$6,0000.00%
MORGAN STANLEY 1,160,098$356,0000.00%
BANK OF MONTREAL /CAN/ 18,333$6,0000.00%
GEODE CAPITAL MANAGEMENT, LLC 102,725$31,0000.00%
View complete list of TRILLIUM THERAPEUTICS INC shareholders